![](https://webarchive.library.unt.edu/eot2008/20090514050329im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514050329im_/http://www.cancer.gov/images/spacer.gif)
| A substance being studied in the treatment of certain types of head and neck cancer. VB4-845 is made by linking a monoclonal antibody fragment to a toxic protein that may kill cancer cells. It binds to EpCAM (a protein on the surface of epithelial cells and some types of cancer cells). Also called anti-EpCAM-Pseudomonas-exotoxin fusion protein and Proxinium. |
Previous Definitions: | vascular endothelial growth factor receptor tyrosine kinase inhibitor, vascular endothelial growth factor, vasectomy, vasomotor, vatalanib | Next Definitions: | Vectibix, vegan, VEGF, VEGF Trap, VEGF-AS |
|
![](https://webarchive.library.unt.edu/eot2008/20090514050329im_/http://www.cancer.gov/images/spacer.gif) |